TELA Bio, Inc.
TELA· Nasdaq
TELATELA Bio, Inc.
Filed Aug 12, 2021 · 10-Q · 43 days after period end · 0001558370-21-011474
| Metric | Q2 2021 | Q2 2020 | Q2 2019 |
|---|---|---|---|
| Revenue | $7.56M | $3.51M | $3.30M |
| Net Income | -$8.26M | -$6.08M | -$5.26M |
| EPS Diluted | -$0.57 | -$0.53 | -$27.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
TELA Bio, Inc. · CIK 1561921 · Engraved from SEC EDGAR
ended Jun 30, 2021 · filed Aug 12, 2021 · 43 d after period end
